Cited by 258Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient OutcomesSchizophrenia research and treatment

Mortality Risk in Patients With Dementia Treated With Antipsychotics Versus Other Psychiatric Medications

Kales, Helen C., Valenstein, Marcia, Kim, H. Myra, McCarthy, John F., Ganoczy, Dara, Cunningham, Francesca, Blow, Frederic C.·2007·American Journal of Psychiatry

Abstract

OBJECTIVE: Mortality rates in the year following new antipsychotic medication starts for neuropsychiatric symptoms of dementia were compared with rates after starts of other psychiatric medications. METHOD: The retrospective, cohort study used national data from the Department of Veterans Affairs (fiscal years 2001-2005) on patients older than 65 years who began outpatient treatment with psychiatric medication following a dementia diagnosis (N=10,615). Twelve-month mortality rates were compared in patients taking antipsychotics and those taking other psychiatric medications. The authors controlled for confounding by using multivariate models and propensity-scoring methods. Secondary analyses included a no-medication group and examination of mortality causes. RESULTS: All groups taking antipsychotics had significantly higher mortality rates (22.6%-29.1%) than patients taking nonantipsychotic medications (14.6%). Adjusted mortality risks for atypicals and for combined atypical and conventional antipsychotics were similar to those for conventional antipsychotics. The mortality risk was significantly lower for nonantipsychotic medications than conventional antipsychotics. Except for anticonvulsants, the adjusted risks for all individual classes of nonantipsychotics were significantly lower than the risk for antipsychotics. Mortality risks did not change over 12 months. The proportions of patients taking antipsychotics who died from cerebrovascular, cardiovascular, or infectious causes were not higher than rates for those taking nonantipsychotic psychiatric medications. CONCLUSIONS: Antipsychotic medications taken by patients with dementia were associated with higher mortality rates than were most other medications used for neuropsychiatric symptoms. The association between mortality and antipsychotics is not well understood and may be due to a direct medication effect or the pathophysiology underlying neuropsychiatric symptoms that prompt antipsychotic use.

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2007.06101710

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Subsequent observational studies have confirmed concerns about increased mortality in patients with dementia with conventional antipsychotics versus atypical antipsychotics, and atypical antipsychotics versus other psychotropic drugs.

    “Subsequent observational studies have confirmed concerns about increased mortality in patients with dementia with conventional antipsychotics versus atypical antipsychotics,121 and atypical antipsychotics versus other psychotropic drugs.122”
  • The guidelines discuss the risks of use of antipsychotic drugs but do not detail the literature for comparative risk between individual antipsychotics and with other psychotropic drugs.

    “In terms of pharmacologic strategies, the guidelines discuss the risks of use of antipsychotic drugs but also do not detail the literature for comparative risk between individual antipsychotics and with other psychotropic drugs.122 126”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kales, H. C., Valenstein, M., Kim, H. M., McCarthy, J. F., Ganoczy, D., Cunningham, F., & Blow, F. C.
Affiliations
Health Services Research & Development (US)
Venue
American Journal of Psychiatry
Published
2007-10
Volume
164
Issue
10
Pages
1568-1576
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2123182031
Cited by
258
References
36
Citations by year
2026: 5 · 2025: 1 · 2024: 5 · 2023: 4 · 2022: 8 · 2021: 8 · 2020: 9 · 2019: 11 · 2018: 15 · 2017: 9 · 2016: 21 · 2015: 22 · 2014: 19 · 2013: 31 · 2012: 21
FWCI
9.66
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
dementia, antipsychotic drugs, mortality risk, neuropsychiatric symptoms, psychiatric medication, atypical antipsychotics, typical antipsychotics, antiepileptic drugs, older adults, veterans, causes of death
MeSH terms
Aged, Ambulatory Care, Cause of Death, Cholinesterase Inhibitors, Dementia, Female, Humans, Longitudinal Studies, Male, Psychotropic Drugs, Registries, Risk Factors, Severity of Illness Index, Antipsychotic Agents, United States, United States Department of Veterans Affairs, Cohort Studies, Comorbidity, Survival Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review